PHARMA INVEST
0449.788.505 · rovalta.com · 26/09/2026
PHARMA INVEST
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPHARMA INVEST is a Public limited company incorporated in 1993. Its registered office is in Uccle.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0449.788.505
- Incorporation
- 31/03/1993
- Legal form
- Public limited company
- Registered office
- Chaussée de Waterloo 799
1180 Uccle · BruxellesSee on map - Contributed capital
- 396 629,64 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 20 filingsTrend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 41,4 k € | -59.7% | 102,9 k € | +44.1% | 71,4 k € | -3.7% | 74,2 k € | -2.9% | 76,4 k € |
| EBITDA | 41,4 k € | -59.7% | 102,9 k € | +44.1% | 71,4 k € | -3.7% | 74,2 k € | -2.9% | 76,4 k € |
| Operating result | 28,9 k € | -67.0% | 87,6 k € | +2680% | 3,2 k € | -95.5% | 69,8 k € | -3.0% | 72 k € |
| Net result | 22,2 k € | -66.1% | 65,3 k € | +3021% | 2,1 k € | -95.8% | 50,1 k € | -3.0% | 51,6 k € |
| Balance sheet | |||||||||
| Equity | 726,4 k € | +3.1% | 704,2 k € | +10.2% | 638,9 k € | +0.3% | 636,8 k € | +8.5% | 586,7 k € |
| Total assets | 822,6 k € | +5.6% | 778,9 k € | +11.3% | 699,6 k € | -0.5% | 703,2 k € | -41.6% | 1,2 M € |
| Cash | 180,6 k € | +55.2% | 116,3 k € | +339% | 26,5 k € | +28.5% | 20,6 k € | -55.3% | 46,1 k € |
| Debts | 94 k € | +25.9% | 74,7 k € | +27.6% | 58,5 k € | -8.8% | 64,2 k € | -89.6% | 615,3 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/2024Other companies at this address
Chaussée de Waterloo 799 1180 Uccle| Company | CBE no. |
|---|---|
SOPHAGEM● Active | 0893.818.475 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 24/08/2026 | 30/07/2025 | 30/08/2024 | 29/06/2023 | 13/07/2022 | 30/08/2021 |
| General meeting | 02/06/2026 | 03/06/2025 | 04/06/2024 | 06/06/2023 | 07/06/2022 | 01/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 02/06/2026 | 24/08/2026 | French | |
| Abridged model | 31/12/2024 | 03/06/2025 | 30/07/2025 | French | |
| Abridged model | 31/12/2023 | 04/06/2024 | 30/08/2024 | French | |
| Abridged model | 31/12/2022 | 06/06/2023 | 29/06/2023 | French | |
| Abridged model | 31/12/2021 | 07/06/2022 | 13/07/2022 | French | |
| Abridged model | 31/12/2020 | 01/06/2021 | 30/08/2021 | French | |
| Micro model | 31/12/2019 | 02/06/2020 | 22/06/2020 | French | |
| Micro model | 31/12/2018 | 04/06/2019 | 07/08/2019 | French | |
| Abridged model | 31/12/2017 | 05/06/2018 | 27/06/2018 | French | |
| Abridged model | 31/12/2016 | 06/06/2017 | 28/07/2017 | French | |
| Abridged model | 31/12/2015 | 07/06/2016 | 02/08/2016 | French | |
| Abridged model | 31/12/2014 | 02/06/2015 | 23/07/2015 | French | |
| Abridged model | 31/12/2013 | 03/06/2014 | 11/07/2014 | French | |
| Abridged model | 31/12/2012 | 04/06/2013 | 25/07/2013 | French | |
| Abridged model | 31/12/2011 | 05/06/2012 | 27/08/2012 | French | |
| Abridged model | 31/12/2010 | 07/06/2011 | 17/06/2011 | French | |
| Abridged model | 31/12/2009 | 01/06/2010 | 23/11/2010 | French | |
| Abridged model | 31/12/2008 | 02/06/2009 | 26/08/2009 | French | |
| Abridged model | 31/12/2007 | 03/06/2008 | 25/07/2008 | French | |
| Abridged model | 31/12/2006 | 05/06/2007 | 17/07/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/2024Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202522,2 k €↓
- 2024Annual accounts 202465,3 k €↑
- 2023Annual accounts 20232,1 k €↓
- 2022Annual accounts 202250,1 k €↓
- 2021Annual accounts 202151,6 k €↑
- 2020Annual accounts 202051 k €↑
- 2019Annual accounts 201944,5 k €↑
- 2018Annual accounts 201843,6 k €↑
- 2017Annual accounts 201739,2 k €↓
- 2016Annual accounts 201647,1 k €↑
- 2015Annual accounts 201545,3 k €↓
- 2014Annual accounts 201484,9 k €↑
- 2013Annual accounts 201380,9 k €↑
- 2012Annual accounts 201275,5 k €↓
- 2011Annual accounts 201191,9 k €↑
- 2010Annual accounts 201069,8 k €↓
- 2009Annual accounts 200980,8 k €↓
- 2008Annual accounts 2008806,3 k €↑
- 2007Annual accounts 200716,6 k €↓
- 2006Annual accounts 200618,4 k €
- 31/03/1993IncorporationPublic limited company